356 related articles for article (PubMed ID: 29127596)
21. Quality of life in patients of chronic lymphocytic leukemia using the EORTC QLQ-C30 and QLQ-CLL17 questionnaire.
Youron P; Singh C; Jindal N; Malhotra P; Khadwal A; Jain A; Prakash G; Varma N; Varma S; Lad DP
Eur J Haematol; 2020 Dec; 105(6):755-762. PubMed ID: 32748412
[TBL] [Abstract][Full Text] [Related]
22. The EORTC QLQ-HDC29: a supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation.
Velikova G; Weis J; Hjermstad MJ; Kopp M; Morris P; Watson M; Sezer O;
Eur J Cancer; 2007 Jan; 43(1):87-94. PubMed ID: 17081744
[TBL] [Abstract][Full Text] [Related]
23. Symptoms and quality of life in chronic pancreatitis assessed by structured interview and the EORTC QLQ-C30 and QLQ-PAN26.
Fitzsimmons D; Kahl S; Butturini G; van Wyk M; Bornman P; Bassi C; Malfertheiner P; George SL; Johnson CD
Am J Gastroenterol; 2005 Apr; 100(4):918-26. PubMed ID: 15784041
[TBL] [Abstract][Full Text] [Related]
24. Development of a disease-specific health-related quality of life questionnaire (THYCA-QoL) for thyroid cancer survivors.
Husson O; Haak HR; Mols F; Nieuwenhuijzen GA; Nieuwlaat WA; Reemst PH; Huysmans DA; Toorians AW; van de Poll-Franse LV
Acta Oncol; 2013 Feb; 52(2):447-54. PubMed ID: 23013266
[TBL] [Abstract][Full Text] [Related]
25. International development of an EORTC questionnaire for assessing health-related quality of life in chronic myeloid leukemia patients: the EORTC QLQ-CML24.
Efficace F; Baccarani M; Breccia M; Saussele S; Abel G; Caocci G; Guilhot F; Cocks K; Naeem A; Sprangers M; Oerlemans S; Chie W; Castagnetti F; Bombaci F; Sharf G; Cardoni A; Noens L; Pallua S; Salvucci M; Nicolatou-Galitis O; Rosti G; Mandelli F
Qual Life Res; 2014 Apr; 23(3):825-36. PubMed ID: 24026634
[TBL] [Abstract][Full Text] [Related]
26. Quality of life measurement in oncology--a matter of the assessment instrument?
Holzner B; Kemmler G; Sperner-Unterweger B; Kopp M; Dünser M; Margreiter R; Marschitz I; Nachbaur D; Fleischhacker WW; Greil R
Eur J Cancer; 2001 Dec; 37(18):2349-56. PubMed ID: 11720827
[TBL] [Abstract][Full Text] [Related]
27. Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30.
Kemmler G; Holzner B; Kopp M; Dünser M; Margreiter R; Greil R; Sperner-Unterweger B
J Clin Oncol; 1999 Sep; 17(9):2932-40. PubMed ID: 10561373
[TBL] [Abstract][Full Text] [Related]
28. Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer.
Vickery CW; Blazeby JM; Conroy T; Arraras J; Sezer O; Koller M; Rosemeyer D; Johnson CD; Alderson D;
Eur J Cancer; 2001 May; 37(8):966-71. PubMed ID: 11334720
[TBL] [Abstract][Full Text] [Related]
29. Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. The EORTC Quality of Life Study Group.
Blazeby JM; Alderson D; Winstone K; Steyn R; Hammerlid E; Arraras J; Farndon JR
Eur J Cancer; 1996 Oct; 32A(11):1912-7. PubMed ID: 8943674
[TBL] [Abstract][Full Text] [Related]
30. The validity of EORTC QLQ-C30 fatigue scale in advanced cancer patients and cancer survivors.
Knobel H; Loge JH; Brenne E; Fayers P; Hjermstad MJ; Kaasa S
Palliat Med; 2003 Dec; 17(8):664-72. PubMed ID: 14694917
[TBL] [Abstract][Full Text] [Related]
31. Phase III development of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire module for women undergoing breast reconstruction.
Winters ZE; Balta V; Thomson HJ; Brandberg Y; Oberguggenberger A; Sinove Y; Unukovych D; Nava M; Sandelin K; Johansson H; ; Dobbeleir J; Blondeel P; Bruno N; Catanuto G; Llewellyn-Bennett R
Br J Surg; 2014 Mar; 101(4):371-82. PubMed ID: 24474151
[TBL] [Abstract][Full Text] [Related]
32. Development of an EORTC quality of life phase III module measuring cancer-related fatigue (EORTC QLQ-FA13).
Weis J; Arraras JI; Conroy T; Efficace F; Fleissner C; Görög A; Hammerlid E; Holzner B; Jones L; Lanceley A; Singer S; Wirtz M; Flechtner H; Bottomley A
Psychooncology; 2013 May; 22(5):1002-7. PubMed ID: 22565359
[TBL] [Abstract][Full Text] [Related]
33. Improvements in Health-related Quality of Life and Symptoms in Patients With Previously Untreated Chronic Lymphocytic Leukemia: Final Results From the Phase II GIBB Study of the Combination of Obinutuzumab and Bendamustine.
Danilov AV; Yimer HA; Boxer MA; Burke JM; Babu S; Li J; Mun Y; Trask PC; Masaquel AS; Sharman JP
Clin Lymphoma Myeloma Leuk; 2022 Feb; 22(2):121-128. PubMed ID: 34674981
[TBL] [Abstract][Full Text] [Related]
34. An international study to revise the EORTC questionnaire for assessing quality of life in lung cancer patients.
Koller M; Hjermstad MJ; Tomaszewski KA; Tomaszewska IM; Hornslien K; Harle A; Arraras JI; Morag O; Pompili C; Ioannidis G; Georgiou M; Navarra C; Chie WC; Johnson CD; Himpel A; Schulz C; Bohrer T; Janssens A; Kuliś D; Bottomley A
Ann Oncol; 2017 Nov; 28(11):2874-2881. PubMed ID: 28945875
[TBL] [Abstract][Full Text] [Related]
35. International validation of the EORTC QLQ-PRT20 module for assessment of quality of life symptoms relating to radiation proctitis: a phase IV study.
Halkett GKB; Wigley CA; Aoun SM; Portaluri M; Tramacere F; Livi L; Detti B; Arcangeli S; Lund JA; Kristensen A; McFadden N; Grun A; Bydder S; Sackerer I; Greimel E; Spry N;
Radiat Oncol; 2018 Aug; 13(1):162. PubMed ID: 30157890
[TBL] [Abstract][Full Text] [Related]
36. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24.
Greimel ER; Kuljanic Vlasic K; Waldenstrom AC; Duric VM; Jensen PT; Singer S; Chie W; Nordin A; Bjelic Radisic V; Wydra D;
Cancer; 2006 Oct; 107(8):1812-22. PubMed ID: 16977652
[TBL] [Abstract][Full Text] [Related]
37. EORTC QLQ-COMU26: a questionnaire for the assessment of communication between patients and professionals. Phase III of the module development in ten countries.
Arraras JI; Wintner LM; Sztankay M; Tomaszewski KA; Hofmeister D; Costantini A; Bredart A; Young T; Kuljanic K; Tomaszewska IM; Kontogianni M; Chie WC; Kulis D; Greimel E;
Support Care Cancer; 2017 May; 25(5):1485-1494. PubMed ID: 28025709
[TBL] [Abstract][Full Text] [Related]
38. Cross-cultural development of a quality-of-life measure for patients with melanoma: phase 3 testing of an EORTC Melanoma Module.
Winstanley JB; Young TE; Boyle FM; Bergenmar M; Bottomley A; Burmeister B; Campana LG; Garioch JJ; King M; Nikolic DV; van de Poll-Franse LV; Saw R; Thompson JF; White EG;
Melanoma Res; 2015 Feb; 25(1):47-58. PubMed ID: 25325247
[TBL] [Abstract][Full Text] [Related]
39. Melanoma in patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma.
Famenini S; Martires KJ; Zhou H; Xavier MF; Wu JJ
J Am Acad Dermatol; 2015 Jan; 72(1):78-84. PubMed ID: 25440434
[TBL] [Abstract][Full Text] [Related]
40. Development of an EORTC questionnaire module to be used in health-related quality-of-life assessment for patients with multiple myeloma. European Organization for Research and Treatment of Cancer Study Group on Quality of Life.
Stead ML; Brown JM; Velikova G; Kaasa S; Wisløff F; Child JA; Hippe E; Hjorth M; Sezer O; Selby P
Br J Haematol; 1999 Mar; 104(3):605-11. PubMed ID: 10086801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
